These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 14676204)
21. The development of MetAP-2 inhibitors in cancer treatment. Yin SQ; Wang JJ; Zhang CM; Liu ZP Curr Med Chem; 2012; 19(7):1021-35. PubMed ID: 22229417 [TBL] [Abstract][Full Text] [Related]
22. Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2). Garrabrant T; Tuman RW; Ludovici D; Tominovich R; Simoneaux RL; Galemmo RA; Johnson DL Angiogenesis; 2004; 7(2):91-6. PubMed ID: 15516829 [TBL] [Abstract][Full Text] [Related]
23. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023 [TBL] [Abstract][Full Text] [Related]
24. Methionine aminopeptidases type I and type II are essential to control cell proliferation. Bernier SG; Taghizadeh N; Thompson CD; Westlin WF; Hannig G J Cell Biochem; 2005 Aug; 95(6):1191-203. PubMed ID: 15962312 [TBL] [Abstract][Full Text] [Related]
25. A chemical and genetic approach to the mode of action of fumagillin. Zhang Y; Yeh JR; Mara A; Ju R; Hines JF; Cirone P; Griesbach HL; Schneider I; Slusarski DC; Holley SA; Crews CM Chem Biol; 2006 Sep; 13(9):1001-9. PubMed ID: 16984890 [TBL] [Abstract][Full Text] [Related]
26. Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry. Shimizu S; Kawahara R; Simizu S Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34913067 [TBL] [Abstract][Full Text] [Related]
27. Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470. Alvarado JJ; Nemkal A; Sauder JM; Russell M; Akiyoshi DE; Shi W; Almo SC; Weiss LM Mol Biochem Parasitol; 2009 Dec; 168(2):158-67. PubMed ID: 19660503 [TBL] [Abstract][Full Text] [Related]
28. Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours. Mauriz JL; Martín-Renedo J; García-Palomo A; Tuñón MJ; González-Gallego J Curr Drug Targets; 2010 Nov; 11(11):1439-57. PubMed ID: 20583970 [TBL] [Abstract][Full Text] [Related]
29. Structural basis for the functional differences between type I and type II human methionine aminopeptidases. Addlagatta A; Hu X; Liu JO; Matthews BW Biochemistry; 2005 Nov; 44(45):14741-9. PubMed ID: 16274222 [TBL] [Abstract][Full Text] [Related]
30. Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. Arfin SM; Kendall RL; Hall L; Weaver LH; Stewart AE; Matthews BW; Bradshaw RA Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7714-8. PubMed ID: 7644482 [TBL] [Abstract][Full Text] [Related]
31. Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo. Didier PJ; Phillips JN; Kuebler DJ; Nasr M; Brindley PJ; Stovall ME; Bowers LC; Didier ES Antimicrob Agents Chemother; 2006 Jun; 50(6):2146-55. PubMed ID: 16723577 [TBL] [Abstract][Full Text] [Related]
32. Yeast methionine aminopeptidase I. Alteration of substrate specificity by site-directed mutagenesis. Walker KW; Bradshaw RA J Biol Chem; 1999 May; 274(19):13403-9. PubMed ID: 10224104 [TBL] [Abstract][Full Text] [Related]
33. Cloning, expression, and characterization of a methionyl aminopeptidase from a hyperthermophilic archaeon Thermococcus sp. NA1. Lee HS; Kim YJ; Bae SS; Jeon JH; Lim JK; Jeong BC; Kang SG; Lee JH Mar Biotechnol (NY); 2006; 8(4):425-32. PubMed ID: 16761197 [TBL] [Abstract][Full Text] [Related]
34. TNP-470: an angiogenesis inhibitor in clinical development for cancer. Kruger EA; Figg WD Expert Opin Investig Drugs; 2000 Jun; 9(6):1383-96. PubMed ID: 11060750 [TBL] [Abstract][Full Text] [Related]
35. The C. elegans methionine aminopeptidase 2 analog map-2 is required for germ cell proliferation. Boxem M; Tsai CW; Zhang Y; Saito RM; Liu JO FEBS Lett; 2004 Oct; 576(1-2):245-50. PubMed ID: 15474045 [TBL] [Abstract][Full Text] [Related]
36. Functional expression of human methionine aminopeptidase type 1 in Saccharomyces cerevisiae. Dummitt B; Fei Y; Chang YH Protein Pept Lett; 2002 Aug; 9(4):295-303. PubMed ID: 12144506 [TBL] [Abstract][Full Text] [Related]
37. Yeast methionine aminopeptidase I can utilize either Zn2+ or Co2+ as a cofactor: a case of mistaken identity? Walker KW; Bradshaw RA Protein Sci; 1998 Dec; 7(12):2684-7. PubMed ID: 9865965 [TBL] [Abstract][Full Text] [Related]
38. Two methionine aminopeptidases from Acinetobacter baumannii are functional enzymes. Yuan H; Chai SC; Lam CK; Howard Xu H; Ye QZ Bioorg Med Chem Lett; 2011 Jun; 21(11):3395-8. PubMed ID: 21524572 [TBL] [Abstract][Full Text] [Related]
39. Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Yeh JJ; Ju R; Brdlik CM; Zhang W; Zhang Y; Matyskiela ME; Shotwell JD; Crews CM Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10379-10384. PubMed ID: 16790550 [TBL] [Abstract][Full Text] [Related]
40. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. Endo H; Takenaga K; Kanno T; Satoh H; Mori S J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]